For research use only. Not for therapeutic Use.
EC5026 (BPN-19186) is a first-in-class, non-opioid and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain[1].<br>EC5026 (BPN-19186) has already shown efficacy for treating pain with no apparent adverse or addictive effects in laboratory animals and relieving naturally occurring pain in dogs, cats and horses[1].
| Catalog Number | I016866 |
| CAS Number | 1809885-32-2 |
| Molecular Formula | C₁₈H₂₃F₄N₃O₃ |
| Purity | ≥95% |
| Reference | [1]. EicOsis Announces FDA Acceptance of IND Application for EC5026, the First Soluble Epoxide Hydrolase Inhibitor to Treat Pain.2019. |
